Cargando…
5-Deazaflavin derivatives as inhibitors of p53 ubiquitination by HDM2()
Based on previous reports of certain 5-deazaflavin derivatives being capable of activating the tumour suppressor p53 in cancer cells through inhibition of the p53-specific ubiquitin E3 ligase HDM2, we have conducted an structure–activity relationship (SAR) analysis through systematic modification of...
Autores principales: | Dickens, Michael P., Roxburgh, Patricia, Hock, Andreas, Mezna, Mokdad, Kellam, Barrie, Vousden, Karen H., Fischer, Peter M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898830/ https://www.ncbi.nlm.nih.gov/pubmed/24113239 http://dx.doi.org/10.1016/j.bmc.2013.09.038 |
Ejemplares similares
-
Efficient Microwave-Assisted Synthesis of 5-Deazaflavine Derivatives
por: Trilleras, Jorge, et al.
Publicado: (2010) -
Deazaflavin reductive photocatalysis involves excited semiquinone radicals
por: Graml, Andreas, et al.
Publicado: (2020) -
p53-mediated adaptation to serine starvation is retained by a common tumour-derived mutant
por: Humpton, Timothy J., et al.
Publicado: (2018) -
Oligobenzamide proteomimetic inhibitors of the p53–hDM2 protein–protein interaction
por: Plante, Jeffrey P., et al.
Publicado: (2009) -
iRFP Is a Real Time Marker for Transformation Based Assays in High Content Screening
por: Paulus-Hock, Viola, et al.
Publicado: (2014)